IDH mutation clearance and MRD status in patients with a best response of CR/CRi/CRp
| Treatment . | n . | IDH mutation clearance, n (%) . | n . | MRD−, n (%) . |
|---|---|---|---|---|
| Ivosidenib + chemotherapy | 41 | 16 (39) | 20 | 16 (80) |
| Enasidenib + chemotherapy | ||||
| Total | 64 | 15 (23) | 16 | 10 (62) |
| R140 | 47 | 11 (23) | 12 | 8 (67) |
| R172 | 17 | 4 (24) | 4 | 2 (50) |
| Treatment . | n . | IDH mutation clearance, n (%) . | n . | MRD−, n (%) . |
|---|---|---|---|---|
| Ivosidenib + chemotherapy | 41 | 16 (39) | 20 | 16 (80) |
| Enasidenib + chemotherapy | ||||
| Total | 64 | 15 (23) | 16 | 10 (62) |
| R140 | 47 | 11 (23) | 12 | 8 (67) |
| R172 | 17 | 4 (24) | 4 | 2 (50) |